Education
About Us
Working with TipRanks
Follow Us
Repro-Med Systems, Inc. (KRMD)
:KRMD
KRMD Stock Chart & Stats
$4.14
<$0.01(0.25%)
At close: 4:00 PM EST
$4.14
<$0.01(0.25%)
Day’s Range― - ―
52-Week Range$1.86 - $6.11
Previous CloseN/A
Volume31.78K
Average Volume (3M)91.82K
Market Cap
$178.47M
Enterprise Value$160.79M
Total Cash (Recent Filing)$8.46M
Total Debt (Recent Filing)$3.67M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Mar 04, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding46,234,960
10 Day Avg. Volume54,917
30 Day Avg. Volume91,822
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)10.49
Price to Sales (P/S)5.24
P/FCF Ratio-109.04
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue4.12
Enterprise Value/Gross Profit6.60
Enterprise Value/Ebitda-50.28
Forecast
1Y Price Target
$5.00Price Target Upside20.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market ExpansionContinued upside potential from OUS expansion into current and new markets as KRMD works to increase its market share internationally, including pre-filled syringe tender opportunities.
Product InnovationInnovation is ongoing with multiple expected 510(K) submissions in 2025 and 2026 across its core platform and novel therapies, with four new drug additions expected on FREEDOM by the end of 2026.
Revenue GrowthKRMD raised its revenue guidance, reflecting growth of now 20-22%, underpinned by SCIg market growth, global share gains, NRE revenue from 4 new PST collaborations, and its flow controller line extension.
Bears Say
REPRO-MED Systems News
KRMD FAQ
What was Repro-Med Systems, Inc.’s price range in the past 12 months?
Repro-Med Systems, Inc. lowest stock price was $1.86 and its highest was $6.11 in the past 12 months.
What is Repro-Med Systems, Inc.’s market cap?
Repro-Med Systems, Inc.’s market cap is $178.47M.
When is Repro-Med Systems, Inc.’s upcoming earnings report date?
Repro-Med Systems, Inc.’s upcoming earnings report date is Mar 04, 2026 which is in 89 days.
How were Repro-Med Systems, Inc.’s earnings last quarter?
Repro-Med Systems, Inc. released its earnings results on Nov 12, 2025. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.024 by $0.004.
Is Repro-Med Systems, Inc. overvalued?
According to Wall Street analysts Repro-Med Systems, Inc.’s price is currently Undervalued.
Does Repro-Med Systems, Inc. pay dividends?
Repro-Med Systems, Inc. does not currently pay dividends.
What is Repro-Med Systems, Inc.’s EPS estimate?
Repro-Med Systems, Inc.’s EPS estimate is -0.02.
How many shares outstanding does Repro-Med Systems, Inc. have?
Repro-Med Systems, Inc. has 46,234,960 shares outstanding.
What happened to Repro-Med Systems, Inc.’s price movement after its last earnings report?
Repro-Med Systems, Inc. reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.024. Following the earnings report the stock price went up 15.079%.
Which hedge fund is a major shareholder of Repro-Med Systems, Inc.?
Currently, no hedge funds are holding shares in KRMD
REPRO-MED Systems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.00 (20.77% Upside)
$5.00 (20.77% Upside)
Blogger Sentiment
Bullish
KRMD Sentiment 70%
Sector Average 68%
Sector Average 68%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.29%
12-Months-Change
Fundamentals
Return on Equity
-21.71%
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Company Description
Repro-Med Systems, Inc.
REPRO-MED Systems, Inc. (KRMD) is a medical technology company that specializes in the development and commercialization of innovative medical devices and services for patients with chronic conditions. The company primarily focuses on the areas of infusion therapy, specifically in the management of patients requiring subcutaneous drug delivery. Its core products include the DME (Durable Medical Equipment) infusion pump systems, which are designed to improve the quality of life for patients with complex medical needs.
KRMD Company Deck
KRMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, particularly from international markets, and successful strategic advancements in oncology and other areas. However, challenges such as domestic revenue decline, gross margin pressure, and some pipeline delays were noted.View all KRMD earnings summariesKRMD Stock 12 Month Forecast
Average Price Target
$5.00
▲(20.77% Upside)
Technical Analysis
InfuSystem Holdings
―
Orasure Technologies
―
Utah Medical Products
―
Microbot Medical
―
Sharps Technology, Inc.
―
Ownership Overview
18.02% Insiders
7.88% Mutual Funds
25.23% Other Institutional Investors
41.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---